loadpatents
name:-0.019707918167114
name:-0.011080026626587
name:-0.0004880428314209
Huwe; Christoph Patent Filings

Huwe; Christoph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huwe; Christoph.The latest application filed is for "progesterone receptor antagonists".

Company Profile
0.11.14
  • Huwe; Christoph - Berlin N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Progesterone receptor antagonists
Grant 9,109,004 - Schwede , et al. August 18, 2
2015-08-18
Progesterone receptor antagonists
Grant 9,085,603 - Schwede , et al. July 21, 2
2015-07-21
Progesterone Receptor Antagonists
App 20130072464 - Schwede; Wolfgang ;   et al.
2013-03-21
Progesterone Receptor Antagonists
App 20130005697 - Schwede; Wolfgang ;   et al.
2013-01-03
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
Grant 7,750,000 - Prien , et al. July 6, 2
2010-07-06
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,598,260 - Brumby , et al. October 6, 2
2009-10-06
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,504,410 - Bryant , et al. March 17, 2
2009-03-17
1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the EP2 receptor
App 20080125435 - Brauer; Nico ;   et al.
2008-05-29
Quinoline derivatives, their preparation, their use, and medicaments comprising them
App 20080056987 - Prien; Olaf ;   et al.
2008-03-06
CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20080039447 - Brumby; Thomas ;   et al.
2008-02-14
Substituted Isoxazolines, Pharmaceutical Compositions Containing Same, Methods Of Preparing Same, And Uses Of Same
App 20080027059 - Brittain; Dominic E.A. ;   et al.
2008-01-31
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
Grant 7,291,624 - Brumby , et al. November 6, 2
2007-11-06
Fluorenes and carbazoles as ligands of the EP2 receptor
App 20070197524 - Brauer; Nico ;   et al.
2007-08-23
Compound and a composition including such a compound
Grant 7,235,561 - Brumby , et al. June 26, 2
2007-06-26
Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
App 20070129359 - Huwe; Christoph ;   et al.
2007-06-07
Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
App 20070093490 - Prien; Olaf ;   et al.
2007-04-26
Piperazine derivatives that destabilize androgen receptors
Grant 6,861,432 - Cleve , et al. March 1, 2
2005-03-01
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040224966 - Brumby, Thomas ;   et al.
2004-11-11
Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040186118 - Bryant, Judi ;   et al.
2004-09-23
New7.alpha., 17.alpha.-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
Grant 6,767,903 - Cleve , et al. July 27, 2
2004-07-27
CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
App 20040102630 - Brumby, Thomas ;   et al.
2004-05-27
Piperazine derivatives that destabilize androgen receptors
App 20040009969 - Cleve, Arwed ;   et al.
2004-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed